The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with Clostridium butyricum 588Massimiliano Cazzaniga, Alexander Bertuccioli, Marco Cardinali et al.|Microorganisms|2024Cited by 15
The Potential Role of Probiotics, Especially Butyrate Producers, in the Management of Gastrointestinal Mucositis Induced by Oncologic Chemo-RadiotherapyMassimiliano Cazzaniga, Alexander Bertuccioli, Luigina Guasti et al.|International Journal of Molecular Sciences|2024Cited by 13
Clostridium butyricum Strain MIYAIRI 588 (CBM588) as a Precision Probiotic Therapy in the Ketogenic Diet: A Possible Application?Alexander Bertuccioli, Francesco Di Pierro, Marco Cardinali et al.|Microbiology Research|2023Cited by 7
Sports-Related Gastrointestinal Disorders: From the Microbiota to the Possible Role of Nutraceuticals, a Narrative AnalysisAlexander Bertuccioli, Chiara Maria Palazzi, Giordano Bruno Zonzini et al.|Microorganisms|2024Cited by 7
The Role of Targeted Microbiota Therapy in the Prevention and Management of Puerperal MastitisMariarosaria Matera, Ilaria Cavecchia, Chiara Maria Palazzi et al.|Diseases|2025Cited by 4